Microsoft word - schulze cv for web page with jb edits.doc

CURRICULUM VITAE
Keith Edward Schulze, M.D.
OFFICE ADDRESS
Dermatologic Surgery Center of Houston, P.A.
PRESENT TITLE
& AFFILIATION
Co-Director, Cutaneous Surgery and Oncology
WORK HISTORY
University of Texas Health Science Center at Houston 6431 Fannin Houston, Texas 77030
HOSPITAL STAFF
Memorial Hermann Hospital, Houston, Texas PRIVILEGES
St. Luke’s Episcopal Hospital, Houston, Texas Gulf Coast Medical Center, Wharton, Texas
SPECIALTY CERTIFICATION Diplomate, American Board of Dermatology
10/93

POSTGRADUATE TRAINING
FELLOWSHIP
Mohs Surgery and Cutaneous Oncology July 2002 – June 2004 Dermatologic Surgery Center of Houston, P.A. RESIDENCY
The University of Texas Medical School at Houston INTERNSHIP
Internal Medicine July 1989 – June 1990 The University of Texas Medical School at Houston EDUCATION

MEDICAL SCHOOL
University of Texas Medical School at Texas at Houston Honors Alpha Omega Alpha Honor Medical Society, 1988
Eugene D. Jacobson Award of Highest Achievement in UNDERGRADUATE
Texas Lutheran University, Seguin, Texas GPA 4.0/4.0 Dean’s List (All Semesters) Alpha Chi (National Honor Scholarship Society) HIGH SCHOOL
Sharpstown High School, Houston, Texas, 1982 Elected “Most Likely to Succeed”, 1982
LICENSURE
Texas State Board of Medical Examiners H7651 Texas Department of Public Safety, Controlled Substances United States Drug Enforcement Administration Controlled
PROFESSIONAL
Secretary/Treasurer, South Texas Medical Clinics, P.A., ACHIEVEMENTS &
Trustee, St. Thomas Episcopal School, Board of Trustees Life Member of The National Registry of Who’s Who

PROFESSIONAL
Associate Member, American College of Mohs AFFILIATIONS
Micrographic Surgery and Cutaneous Oncology Fellow, American Society for Mohs Surgery Alpha Omega Alpha National Honor Medical Society PUBLICATIONS
Cohen PR, Schulze KE, Teller CF, Nelson, BR: Intralesional methotrexate as effective treatment for keratoacanthoma of the nose. SKINmed: Dermatology for the Clinician, in press. Cohen PR, Schulze KE, Nelson, BR: Cutaneous carcinoma with mixed histology: a potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision. South Med J, in press. Sweeney SA, Cohen PR, Schulze KE, Nelson BR: Familial Median Canaliform Martinelli PT, Schulze KE, Nelson BR: Mohs micrographic surgery in a patient with a deep brain stimulator: A review of the literature on implantable electrical devices. Dermatol Surg 2004;30:1021-1030. Schulze KE, Rapini RP, Duvic M: Malignant melanoma in oculocutaneous albinism. Schulze KE, Cohen PR. Dove-associated gamasoidosis: A case of avian mite dermatitis. Schulze KE, Hebert AA. Diagnostic features, differential diagnosis, and treatment of subungual osteochondroma. Pediatr Dermatol 1994;11:39-41.
CLINICAL RESEARCH

A Prospective, Randomized, Double-Blind, Multicenter, Patient-Initiated Study to Compare the Efficacy of Penciclovir (1%) Cream with Placebo in Recurrent Herpes Simplex Labialis, SmithKline Beecham, Protocol BRL 39123: 3/93 – 6/93. Evaluation of Famciclovir vs. Placebo on Herpes Zoster Induced Pain (including Post-Herpetic), A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study, SmithKline Beecham, Protocol FAM-067: 1/93 – 6/93. Dirithromycin vs. Erythromycin in Skin and Soft Tissue Infections, Lilly/Pharmaco Dynamics, Protocol B9Z-MC-AQAX: 1/93 – 6.93. Co-Investigator. A Comparison Study of the Efficacy and Safety of Augmentin 500/125 mg p.o. q 12 hrs. and Augmentin 250/125 mg p.o. q 8 hrs. in the Treatment of Uncomplicated Skin and Skin Structure Infections, SmithKline Beecham, Protocol 983-013: 7/92 – 2/93. A Double-Blind, Parallel Group Study of the Efficacy and Safety of BMS 181161 (Calcipotriene – A Vitamin D3 Analogue) Ointment 0.005% vs. its Vehicle in the Treatment of Plaque Psoriasis in a Pediatric Population, Bristol-Myers Squibb, Protocol DE127-014-006: 3/92 – 2/93. Co-Investigator. A Double-Blind, Randomized, Comparative, Multicenter Study of CI-983 vs. Cephalexin in the Treatment of Skin and Skin Structure Infections (Pediatric Population), Warner-Lambert/Parke Davis, Protocol CI9830013: 6/92 – 6/93. Co-Investigator. Fusidic Acid vs. Erythromycin in the Treatment of Bacterial Folliculitis, Bristol-Myers Squibb, Protocol DE125-002: 1/92 – 6/93. Co-Investigator. A Double-Blind, Randomized, Placebo-Controlled Parallel Group Study to Assess the Safety and Efficacy of Oral BRL 42810 in the Treatment of Patients with Uncomplicated Herpes Zoster. SmithKline Beecham Pharmaceuticals, Protocol 42810/008: 5/91– 6/93. Co-Investigator. A Double Blind, Randomized, Comparative, Multicenter Study of CI-983 (Cefdinir) vs. Cephalexin in the Treatment of Skin and Skin Structure Infections. Parke-Davis Research Division, Protocol 983-8-19: 3/92 – 12/92. Co-Investigator. Safety and Efficacy of AGN 190168 in the Treatment of Acne Vulgaris: AGN 190168 0.1% and 0.5% Gels vs. Vehicle Gel. Herbert Laboratories, Protocol R168-220-7997: 1/17/92 – 6/18/92. Co-Investigator. A Multicenter, Double-Blind Evaluation of Recombinant Human Basic Fibroblast Growth Factor in the Treatment of Diabetic Ulcers. Pharmaco Dynamics Research, Inc., Protocol SID-03/SY02-C90-WH04: 3/5/91 – 1/23/92. Co-Investigator. A Multicenter, Double-Blind Evaluation of Recombinant Human Basic Fibroblast Growth Factor in the Treatment of Venous Stasis and Diabetic Ulcers. Pharmaco Dynamics Research, Inc./Synergen, Inc., Protocol SID-9-03: 7/1/90 – 10/16/91. A Comparison of the Safety and Efficacy of Lomefloxacin and Ciprofloxacin in the Treatment of Non-Necrotizing Skin and Skin Structure Infections. G.D. Searle and Co., Protocol S69-90-02-189: 2/26/91 – 5/2/91. Co-Investigator. Comparative Safety and Efficacy of Clarithromycin and Cefadroxil Suspensions in the Treatment of Children with Mild to Moderate Skin or Skin Structure Infection. Abbott Laboratories, Protocol M90-491: 11/19/90 – 7/8/91. Co-Investigator. A Multicenter, Double-Blind, Vehicle Controlled Study of Topical 5% Spironolactone Cream in the Treatment of Nodulocystic Acne. G.D. Searle and Co., Protocol S84-90-02-016: 3/16/90 – 10/5/90. Co-Investigator. A Multicenter Open Label Study of the Long Term Safety of Topical 5% Spirononlactone Cream in the Treatment of Facial Acne Vulgaris. G.D. Searle and Co., Protocol S84-89-02-019 (Continuation of S84-89-02-014): 4/13/90 – 9/4/90. Co-Investigator.
PROFESSIONAL PRESENTATIONS

Schulze KE, and Hebert AA: Osteochondroma induced onychodystrophy in a 10 year old child. Gross and Microscopic Symposium, American Academy of Dermatology, Dallas, Texas, December 7, 1991. Schulze KE, and Cohen PR: Dove-associated gamasoidosis: A case of avian mite dermatitis. Gross and Microscopic Symposium, American Academy of Dermatology, San Francisco, California, December 5, 1992.

Source: http://www.dermsurgeryhouston.com/schulzecv.pdf